LUMOBRY 0.25mg / ml ophthalmic drops solution medication leaflet

S01GA07 brimonidine • Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants

Brimonidine is a medication used to treat open-angle glaucoma and ocular hypertension. It belongs to the class of alpha-2 adrenergic receptor agonists and works by reducing the production of aqueous humor and increasing its outflow, thereby lowering intraocular pressure.

It is available as eye drops and is typically administered two to three times a day, as directed by a doctor. Brimonidine is effective in preventing optic nerve damage caused by elevated intraocular pressure.

Side effects may include a burning or stinging sensation in the eyes, dry eyes, redness, headache, drowsiness, or dizziness. It is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) and should be used with caution in those with severe cardiovascular conditions.

General data about LUMOBRY 0.25mg / ml

Substance: brimonidine

Date of last drug list: 01-07-2024

Commercial code: W70321001

Concentration: 0.25mg / ml

Pharmaceutical form: ophthalmic drops solution

Quantity: 1

Product type: original

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: BAUSCH+LOMB IRELAND LIMITED - IRLANDA

Holder: BAUSCH+LOMB IRELAND LIMIT - IRLANDA

Number: 15476/2024/01

Shelf life: 2 years-after packaging for sale;after the first opening of the bottle-121 days

Pharmaceutical forms available for brimonidine

Concentrations available for brimonidine

0.25mg/ml, 2mg/ml, 3mg/g

Other substances similar to brimonidine

Combinations with other substances